MOLECULAR SURFACE TECHNOLOGIES LLC

Medtech · Private

Antimicrobial surface coating for medical implants using covalently bound quaternary ammonium-modified oligosaccharides attached via linker molecules to titanium alloy

Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
14
3 granted · 11 pending
Sector median: 2

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1693Agenus Inc.—$221M
1694INTEGUMED, LLC——
1695ZBEATS, INC.——
1696MOLECULAR SURFACE TECHNOLOGIES LLC——
1697TEARDX, LLC——
1698ONTOGEN MEDTECH——
1699Amnio Technology, LLC—$50K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 3 granted of 14

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.